Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Cost of Healthcare

Are Americans Taking Too Many Drugs?

Posted on July 26, 2024 by Devon Herrick

I once read a comment from a doctor who said when he sees seniors who are on a dozen pharmaceutical drugs, half are to treat the side effects of the other half. What effect can too many medications have on seniors? You would be amazed.

+

Friday Links

Posted on July 26, 2024July 26, 2024 by John C. Goodman
  • Poll: Americans overwhelming support polygenic embryo selection for serious disease, but by 45% to 35% oppose selecting for IQ. 
  • How the father’s diet affects the health of the descendants.
  • Why do the richest states get the most Medicaid money?
  • Why are so many scientists around the world engaged in “gain of function” research? Because they can get money to do it.
  • Why progressives should support free trade.
  • Cato study: Occupational licensing disproportionately burdens minority workers.
+

Gain of Function, Loss of … Everything Else

Posted on July 25, 2024 by John C. Goodman

It did not have to be this way. The COVID-19 pandemic cost American citizens their lives, their livelihoods, education, mental health, reputations and, ultimately, civil and religious freedoms. “The U.S. accounts for less than 5% of the world’s population, but more than 25% of total COVID-19 cases reported across the globe, and it currently ranks among the top 10 countries in COVID-19-related deaths per capita,” wrote the authors of  2023 commentary in the Journal of the American Medical Association. And for all that, we have government to thank.  

+

House Oversight Committee: PBMs Increase the Drug Costs

Posted on July 25, 2024 by Devon Herrick

I wrote about pharmacy benefit managers (PBMs) extensively in the past. PBMs are the middlemen who manage pharmacy benefits for employee health plans, Medicare, Medicaid and insurance companies. The concept is simple: PBMs leverage buying power to extract discounts from drug makers. These discounts are (in theory) passed on to consumers and health plan clients. PBMs also create drug formularies and adjudicate drug claims.

+
  • Previous
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 326
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 35 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom